|
SWAP70 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.968200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.846000E-04 |
| Normal-vs-Stage2 |
1.458810E-01 |
| Normal-vs-Stage3 |
1.734260E-02 |
| Normal-vs-Stage4 |
4.48080000000628E-05 |
| Stage1-vs-Stage2 |
4.289600E-01 |
| Stage1-vs-Stage3 |
7.444600E-01 |
| Stage1-vs-Stage4 |
1.546820E-01 |
| Stage2-vs-Stage3 |
6.198600E-01 |
| Stage2-vs-Stage4 |
4.467600E-02 |
| Stage3-vs-Stage4 |
7.104400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.383980E-04 |
| Normal-vs-AfricanAmerican |
9.351500E-02 |
| Normal-vs-Asian |
1.317000E-01 |
| Caucasian-vs-AfricanAmerican |
1.339390E-01 |
| Caucasian-vs-Asian |
8.138400E-01 |
| AfricanAmerican-vs-Asian |
7.786400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.01019999999508E-05 |
| Normal-vs-Female |
2.838000E-01 |
| Male-vs-Female |
3.766000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.824700E-03 |
| Normal-vs-Extreme_Weight |
2.01759999999274E-05 |
| Normal-vs-Obese |
1.154210E-01 |
| Normal-vs-Extreme_Obese |
1.880180E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.678000E-01 |
| Normal_Weight-vs-Obese |
1.945360E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.889400E-01 |
| Extreme_Weight-vs-Obese |
1.942000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.186400E-01 |
| Obese-vs-Extreme_Obese |
1.891050E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.090400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.978100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.85649999999904E-05 |
| Normal-vs-Age(81-100Yrs) |
1.798600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.857400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.074400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.375900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.860000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.552400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.710200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.804800E-04 |
| Normal-VS-Type2 PRCC |
1.350230E-04 |
| Normal-VS-KIRP CIMP |
5.697400E-01 |
| Normal-VS-Unclassified PRCC |
6.810800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.726200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.446200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.291050E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.155400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.391700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.953600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.83659999999964E-05 |
| Normal-vs-N1 |
7.895900E-02 |
| Normal-vs-N2 |
1.488040E-02 |
| N0-vs-N1 |
2.483400E-01 |
| N0-vs-N2 |
7.793200E-01 |
| N1-vs-N2 |
4.549400E-01 |
|
|
